- Home
- ELV vs FBIOP Comparison
ELV vs FBIOP Comparison
Compare ELV & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELV
- FBIOP
- Stock Information
- Founded
- ELV 1944
- FBIOP N/A
- Country
- ELV United States
- FBIOP United States
- Employees
- ELV N/A
- FBIOP 101
- Industry
- ELV Medical Specialities
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- ELV Health Care
- FBIOP Health Care
- Exchange
- ELV Nasdaq
- FBIOP Nasdaq
- Market Cap
- ELV N/A
- FBIOP N/A
- IPO Year
- ELV N/A
- FBIOP N/A
- Fundamental
- Price
- ELV $404.56
- FBIOP $6.35
- Analyst Decision
- ELV Buy
- FBIOP
- Analyst Count
- ELV 15
- FBIOP 0
- Target Price
- ELV $519.76
- FBIOP N/A
- AVG Volume (30 Days)
- ELV 1.4M
- FBIOP N/A
- Earning Date
- ELV 04-22-2025
- FBIOP N/A
- Dividend Yield
- ELV 1.66%
- FBIOP N/A
- EPS Growth
- ELV N/A
- FBIOP N/A
- EPS
- ELV 25.60
- FBIOP N/A
- Revenue
- ELV $183,124,000,000.00
- FBIOP N/A
- Revenue This Year
- ELV $11.06
- FBIOP N/A
- Revenue Next Year
- ELV $7.16
- FBIOP N/A
- P/E Ratio
- ELV $16.11
- FBIOP N/A
- Revenue Growth
- ELV 6.63
- FBIOP N/A
- 52 Week Low
- ELV $362.21
- FBIOP N/A
- 52 Week High
- ELV $567.26
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- ELV 41.09
- FBIOP 47.83
- Support Level
- ELV $406.55
- FBIOP $6.05
- Resistance Level
- ELV $419.99
- FBIOP $6.80
- Average True Range (ATR)
- ELV 10.60
- FBIOP 0.32
- MACD
- ELV -1.50
- FBIOP -0.02
- Stochastic Oscillator
- ELV 8.35
- FBIOP 17.02
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.